{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:34:35Z","timestamp":1774686875518,"version":"3.50.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1097\/qai.0b013e3181a97be5","type":"journal-article","created":{"date-parts":[[2009,6,22]],"date-time":"2009-06-22T09:07:16Z","timestamp":1245661636000},"page":"274-282","source":"Crossref","is-referenced-by-count":47,"title":["Prevalence and Persistence of Cervical Human Papillomavirus Infection in HIV-Positive Women Initiating Highly Active Antiretroviral Therapy"],"prefix":"10.1097","volume":"51","author":[{"given":"Kenneth H","family":"Fife","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia W","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen E","family":"Squires","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Heather","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet W","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darron R","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210131","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM199711063371903","article-title":"Human papillomavirus infection in women infected with the human immunodeficiency virus.","volume":"337","author":"Sun","year":"1997","journal-title":"N Engl J Med"},{"key":"R2-6-20210131","first-page":"1145","article-title":"Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women Clin Infect Dis.","volume":"29","author":"Cu-Uvin","year":"1999","journal-title":""},{"key":"R3-6-20210131","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","article-title":"Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women.","volume":"91","author":"Palefsky","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"R4-6-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mob.2002.119776","article-title":"Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection.","volume":"186","author":"Jamieson","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"R5-6-20210131","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1086\/323081","article-title":"Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women.","volume":"184","author":"Ahdieh","year":"2001","journal-title":"J Infect Dis"},{"key":"R6-6-20210131","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1086\/421467","article-title":"Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.","volume":"190","author":"Moscicki","year":"2004","journal-title":"J Infect Dis"},{"key":"R7-6-20210131","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1086\/520883","article-title":"The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women.","volume":"196","author":"Rowhani-Rahbar","year":"2007","journal-title":"J Infect Dis"},{"key":"R8-6-20210131","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00126334-199905010-00005","article-title":"Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1.","volume":"21","author":"Massad","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-6-20210131","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","article-title":"Incidence of cervical squamous intraepithelial lesions in HIV-infected women.","volume":"283","author":"Ellerbrock","year":"2000","journal-title":"JAMA"},{"key":"R10-6-20210131","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/500404","article-title":"Effect of HIV infection on atypical squamous cells of undetermined significance.","volume":"42","author":"Duerr","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R11-6-20210131","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer.","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"R12-6-20210131","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women.","volume":"338","author":"Ho","year":"1998","journal-title":"N Engl J Med"},{"key":"R13-6-20210131","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.","volume":"337","author":"Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"R14-6-20210131","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less.","volume":"337","author":"Hammer","year":"1997","journal-title":"N Engl J Med"},{"key":"R15-6-20210131","first-page":"185","article-title":"Prevalence of risk factors associated with human papillomavirus infection in women living with HIV.","volume":"160","author":"Hankins","year":"1999","journal-title":"Can Med Assoc J"},{"key":"R16-6-20210131","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/00002030-200008180-00013","article-title":"Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression.","volume":"14","author":"Delmas","year":"2000","journal-title":"AIDS"},{"key":"R17-6-20210131","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ygyno.2003.10.004","article-title":"Presence of multiple human papillomavirus types in cervical samples from HIV-infected women.","volume":"92","author":"Levi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R18-6-20210131","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R19-6-20210131","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/00002030-199812000-00007","article-title":"Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy.","volume":"12","author":"Heard","year":"1998","journal-title":"AIDS"},{"key":"R20-6-20210131","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/322856","article-title":"Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy.","volume":"184","author":"Lillo","year":"2001","journal-title":"J Infect Dis"},{"key":"R21-6-20210131","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00002030-200111090-00011","article-title":"The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women.","volume":"15","author":"Minkoff","year":"2001","journal-title":"AIDS"},{"key":"R22-6-20210131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1258\/095646203765371321","article-title":"Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.","volume":"14","author":"Branca","year":"2003","journal-title":"Int J STD AIDS"},{"key":"R23-6-20210131","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1097\/00002030-200309260-00021","article-title":"Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women.","volume":"17","author":"Uberti-Foppa","year":"2003","journal-title":"AIDS"},{"key":"R24-6-20210131","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jnci\/djh192","article-title":"Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.","volume":"96","author":"Ahdieh-Grant","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R25-6-20210131","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/381681","article-title":"Antiretroviral therapy and the clinical evolution of human papillomavirus-associated genital lesions in HIV-positive women.","volume":"38","author":"Del Mistro","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R26-6-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/AOG.0b013e31819225cb","article-title":"The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology.","volume":"113","author":"Paramsothy","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R27-6-20210131","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","article-title":"The 2001 Bethesda System: terminology for reporting results of cervical cytology.","volume":"287","author":"Solomon","year":"2002","journal-title":"JAMA"},{"key":"R28-6-20210131","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/323660","article-title":"Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.","volume":"184","author":"Coombs","year":"2001","journal-title":"J Infect Dis"},{"key":"R29-6-20210131","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/426867","article-title":"A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women.","volume":"191","author":"Brown","year":"2005","journal-title":"J Infect Dis"},{"key":"R30-6-20210131","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/JCM.38.1.357-361.2000","article-title":"Improved amplification of genital human papillomaviruses.","volume":"38","author":"Gravitt","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R31-6-20210131","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1128\/JCM.36.10.3020-3027.1998","article-title":"Genotyping of 27 HPV types from L1 consensus PCR products using a single hybridization, reverse line-blot detection method.","volume":"36","author":"Gravitt","year":"1998","journal-title":"J Clin Microbiol"},{"key":"R32-6-20210131","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1128\/JCM.37.10.3316-3322.1999","article-title":"Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients.","volume":"37","author":"Brown","year":"1999","journal-title":"J Clin Microbiol"},{"key":"R33-6-20210131","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/jnci\/95.14.1062","article-title":"Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women.","volume":"95","author":"Strickler","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R34-6-20210131","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1086\/505876","article-title":"Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York.","volume":"194","author":"Luque","year":"2006","journal-title":"J Infect Dis"},{"key":"R35-6-20210131","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1038\/sj.bjc.6603737","article-title":"Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.","volume":"96","author":"Sahasrabuddhe","year":"2007","journal-title":"Br J Cancer"},{"key":"R36-6-20210131","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"R37-6-20210131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial.","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncology"},{"key":"R38-6-20210131","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.olq.0000187208.94655.34","article-title":"Human papillomavirus (HPV) detection among human immunodeficiency virus-infected pregnant Thai women: implications for future HPV immunization.","volume":"33","author":"Bollen","year":"2006","journal-title":"Sex Transm Dis"},{"key":"R39-6-20210131","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.23045","article-title":"Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya.","volume":"122","author":"De Vuyst","year":"2008","journal-title":"Int J Cancer"},{"key":"R40-6-20210131","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.296.7.769","article-title":"Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.","volume":"296","author":"Gulick","year":"2006","journal-title":"JAMA"},{"key":"R41-6-20210131","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1097\/01.qai.0000138379.39317.62","article-title":"Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort.","volume":"37","author":"Kuyper","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R42-6-20210131","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.ygyno.2006.06.015","article-title":"Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.","volume":"103","author":"Parham","year":"2006","journal-title":"Gynecol Oncol"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200907010-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T17:18:16Z","timestamp":1633627096000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200907010-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181a97be5","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}